Biomaterial Database

Use of almitrine bismesylate to stimulate ventilation in congenital central hypoventilation. 1983

D C Shannon, and K Sullivan, and L Perret, and D H Kelly

UI	MeSH Term	Description	Entries
D007040	Hypoventilation	A reduction in the amount of air entering the pulmonary alveoli.	Hypoventilations
D007223	Infant	A child between 1 and 23 months of age.	Infants
D008176	Lung Volume Measurements	Measurement of the amount of air that the lungs may contain at various points in the respiratory cycle.	Lung Capacities,Lung Volumes,Capacity, Lung,Lung Capacity,Lung Volume,Lung Volume Measurement,Measurement, Lung Volume,Volume, Lung
D010879	Piperazines	Compounds that are derived from PIPERAZINE.
D002648	Child	A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.	Children
D002675	Child, Preschool	A child between the ages of 2 and 5.	Children, Preschool,Preschool Child,Preschool Children
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014692	Ventilation-Perfusion Ratio	The ratio of alveolar ventilation to simultaneous alveolar capillary blood flow in any part of the lung. (Stedman, 25th ed)	Ratio, Ventilation-Perfusion,Ratios, Ventilation-Perfusion,Ventilation Perfusion Ratio,Ventilation-Perfusion Ratios
D015765	Almitrine	A respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. The drug increases arterial oxygen tension while decreasing arterial carbon dioxide tension in patients with chronic obstructive pulmonary disease. It may also prove useful in the treatment of nocturnal oxygen desaturation without impairing the quality of sleep.	Almitrine Bismesylate,Almitrine Bis(methanesulfonate),Almitrine Dimesylate,Almitrine Monomesylate,Vectarion,Monomesylate, Almitrine